Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Drug Discovery 2025

ELRIG’s Drug Discovery conference returns to Liverpool, continuing its reputation as Europe’s leading event for Drug Discovery and Life Sciences. This year’s scientific programme will [...]

Go to Top